Life Sciences
Research conducted at B. Omathuna and co-authors has provided new information about life sciences
Published in Hospital Business Week, November 16th, 2008
"MDMA is also a mechanism-based inhibitor of CYP2D6. A controlled clinical trial was conducted in 15 healthy male subjects whereby a probe drug, dextromethorphan (DEX), was administered after an oral dose of 1.5 mg/kg MDMA. The pharmacokinetics of DEX and its metabolites were used to evaluate changes in CYP2D6 activity. The urinary metabolic ratio of DEX and dextrorphan was used to calculate a recovery half-life...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- A.M. Best
A.M. Best Special Report: Investments Move to Cash and Short Term as Pressures Mount - Abyssinian Development Corporation
Former President Bill Clinton and Abyssinian Development Corporation Honor Reverend Dr. Calvin O. Butts, III at a Star-Studded White Tie Gala - ACE Vision Group, Inc.
ACE Vision Group, Inc. Announces New Global Medical Director, Dr. Marguerite McDonald - Action Donation Services
Car Donations: 'Tired Wheels' Turned Into Donation Dollars for Ronald McDonald House Charities, San Diego - Addiction Medicine
Gold Standard Re-launches ToxED Clinical Toxicology Poisoning and Drug Overdose Reference - Adolor Corporation
Adolor Corporation Reports Third Quarter 2008 Financial Results - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
